BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17629354)

  • 1. A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Kauer-Sant'Anna M; Andreazza AC; Valvassori SS; Martins MR; Barbosa LM; Schwartsmann G; Roesler R; Quevedo J; Kapczinski F
    Peptides; 2007 Jul; 28(7):1447-52. PubMed ID: 17629354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain.
    Valvassori SS; Moretti M; Kauer-Sant'Anna M; Roesler R; Petronilho F; Schwartsmann G; Kapczinski F; Dal-Pizzol F; Quevedo J
    J Neural Transm (Vienna); 2010 Mar; 117(3):309-16. PubMed ID: 20131069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system.
    Dantas Ados S; Luft T; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2006 Sep; 27(9):2307-12. PubMed ID: 16650508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors.
    Venturella R; Lessa D; Luft T; Roozendaal B; Schwartsmann G; Roesler R
    Peptides; 2005 May; 26(5):821-5. PubMed ID: 15808912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095.
    Martins MR; Reinke A; Valvassori SS; Machado RA; Quevedo J; Schwartsmann G; Roesler R
    Peptides; 2005 Dec; 26(12):2525-9. PubMed ID: 16023260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders.
    Presti-Torres J; de Lima MN; Scalco FS; Caldana F; Garcia VA; Guimarães MR; Schwartsmann G; Roesler R; Schröder N
    Neuropharmacology; 2007 Mar; 52(3):724-32. PubMed ID: 17097693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
    Meller CA; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2004 Apr; 25(4):585-8. PubMed ID: 15165713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania.
    Frey BN; Andreazza AC; Ceresér KM; Martins MR; Valvassori SS; Réus GZ; Quevedo J; Kapczinski F
    Life Sci; 2006 Jun; 79(3):281-6. PubMed ID: 16460767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
    Pereira DV; Steckert AV; Mina F; Petronilho F; Roesler R; Schwartsmann G; Ritter C; Dal-Pizzol F
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5300-3. PubMed ID: 19516017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.
    Valvassori SS; Elias G; de Souza B; Petronilho F; Dal-Pizzol F; Kapczinski F; Trzesniak C; Tumas V; Dursun S; Chagas MH; Hallak JE; Zuardi AW; Quevedo J; Crippa JA
    J Psychopharmacol; 2011 Feb; 25(2):274-80. PubMed ID: 19939866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
    Rezin GT; Petronilho FC; Araújo JH; Gonçalves CL; Daufenbach JF; Cardoso MR; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):214-9. PubMed ID: 21138529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus.
    Roesler R; Luft T; Oliveira SH; Farias CB; Almeida VR; Quevedo J; Dal Pizzol F; Schröder N; Izquierdo I; Schwartsmann G
    Neuropharmacology; 2006 Aug; 51(2):350-7. PubMed ID: 16735043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
    Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
    Frey BN; Andreazza AC; Rosa AR; Martins MR; Valvassori SS; Réus GZ; Hatch JP; Quevedo J; Kapczinski F
    Behav Pharmacol; 2006 Jun; 17(4):311-8. PubMed ID: 16914949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory.
    Luft T; Flores DG; Vianna MR; Schwartsmann G; Roesler R; Izquierdo I
    Neuroreport; 2006 Jun; 17(9):935-9. PubMed ID: 16738491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
    Petronilho F; Araújo JH; Steckert AV; Rezin GT; Ferreira GK; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Peptides; 2009 Aug; 30(8):1460-5. PubMed ID: 19505518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibition prevents the impairing effects of hippocampal gastrin-releasing peptide receptor antagonism on memory consolidation and extinction.
    Petry FS; Dornelles AS; Lichtenfels M; Valiati FE; de Farias CB; Schwartsmann G; Parent MB; Roesler R
    Behav Brain Res; 2016 Jul; 307():46-53. PubMed ID: 27025446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.